The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Pancreatic Cancer Surgery in the New Millennium: Better Prediction of Outcome
Abstract
BACKGROUND: Surgery is the only therapy with potentially curative intention in pancreatic cancer. This analysis aimed to determine prognostic parameters in a patient cohort with resected pancreatic adenocarcinoma with a special focus on the revised R1-definition. METHODS: Between October 2001 and August 2009, data from 1071 consecutively resected patients with pancreatic adenocarcinoma were prospectively collected in an electronical database. Parameters tested for survival prediction in univariate analysis included patient, tumor, and resection characteristics as well as adjuvant therapy. The parameters with significant results were used for multivariate survival analysis. Identified parameters with positive or negative prognostic effect were used to define risk groups and to assess the effects on patient survival. RESULTS: Age, ASA-score, CEA and CA19-9 levels, preoperative insulin-dependent diabetes mellitus, T-, N-, M-, R-, G-tumor classification, advanced disease, and LNR were all significant in univariate analysis, whereas gender, NYHA score, BMI, insurance status, type of surgical procedure, and adjuvant therapy were not. In multivariate analysis, age ≥70 years, preoperative insulin-dependent diabetes, CA19-9 ≥400 U/mL, T4-, M1- or G3-status, and LNR > 0.2 were independent negative predictors, whereas Tis/T1/T2-status, G1-differentiation, and R0-status (revised definition) were independently associated with good prognosis. Using these risk factors, patients were stratified into 4 risk-groups with significantly different prognosis; 5-year survival varied between 0% and 54.5%. Risk stratification resulted in improved survival prognostication within the predominant AJCC IIA and AJCC IIB stages. CONCLUSIONS: A newly defined prognostic profiling including the revised R1-definition discriminates survival of patients with resectable pancreatic adenocarcinoma better than the AJCC staging system, and may be of particular relevance for patient-adjusted therapy in the heterogeneous group of AJCC stage II tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oettle, H., Post, S., Neuhaus, P., Gellert, K., Langrehr, J., Ridwelski, K., Schramm, H., Fahlke, J., Zuelke, C., Burkart, C., et al. (2007) · JAMA · doi:10.1001/jama.297.3.267 · Cited by 2,419
Neoptolemos, J. P., Stocken, D. D., Bassi, C., Ghaneh, P., Cunningham, D., Goldstein, D., Padbury, R., Moore, M. J., Gallinger, S., Mariette, C., et al. (2010) · JAMA · doi:10.1001/jama.2010.1275 · Cited by 1,397
Self-citationOne Thousand Consecutive Pancreaticoduodenectomies
Cameron, J. L., Riall, T. S., Coleman, J., & Belcher, K. A. (2006) · Annals of Surgery · doi:10.1097/01.sla.0000217673.04165.ea · Cited by 1,279
Barone, B. B. (2008) · JAMA · doi:10.1001/jama.2008.824 · Cited by 881
Intraductal Papillary Mucinous Neoplasms of the Pancreas: An Updated Experience
Sohn, T. A., Yeo, C. J., Cameron, J. L., Hruban, R. H., Fukushima, N., Campbell, K. A., & Lillemoe, K. D. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000128306.90650.aa · Cited by 874
Wagner, M., Redaelli, C., Lietz, M., Seiler, C. A., Friess, H., & Büchler, M. W. (2004) · British Journal of Surgery · doi:10.1002/bjs.4484 · Cited by 844
Self-citationYeo, C. J., Cameron, J. L., Lillemoe, K. D., Sohn, T. A., Campbell, K. A., Sauter, P. K., Coleman, J., Abrams, R. A., & Hruban, R. H. (2002) · Annals of Surgery · doi:10.1097/00000658-200209000-00012 · Cited by 807
Salvia, R., Castillo, C. F.-D., Bassi, C., Thayer, S. P., Falconi, M., Mantovani, W., Pederzoli, P., & Warshaw, A. L. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000124386.54496.15 · Cited by 746
Pedrazzoli, S., DiCarlo, V., Dionigi, R., Mosca, F., Pederzoli, P., Pasquali, C., Klöppel, G., Dhaene, K., & Michelassi, F. (1998) · Annals of Surgery · doi:10.1097/00000658-199810000-00007 · Cited by 692
Most Pancreatic Cancer Resections are R1 Resections
Esposito, I., Kleeff, J., Bergmann, F., Reiser, C., Herpel, E., Friess, H., Schirmacher, P., & Büchler, M. W. (2008) · Annals of Surgical Oncology · doi:10.1245/s10434-008-9839-8 · Cited by 645
Self-citationRedefining the R1 resection in pancreatic cancer
Verbeke, C. S., Leitch, D., Menon, K. V., McMahon, M. J., Guillou, P. J., & Anthoney, A. (2006) · British Journal of Surgery · doi:10.1002/bjs.5397 · Cited by 593
Raut, C. P., Tseng, J. F., Sun, C. C., Wang, H., Wolff, R. A., Crane, C. H., Hwang, R., Vauthey, J.-N., Abdalla, E. K., Lee, J. E., et al. (2007) · Annals of Surgery · doi:10.1097/01.sla.0000259391.84304.2b · Cited by 564
Ferrone, C. R., Finkelstein, D. M., Thayer, S. P., Muzikansky, A., Castillo, C. F.-D., & Warshaw, A. L. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.3934 · Cited by 554
Crippa, S., Salvia, R., Warshaw, A. L., Domínguez, I., Bassi, C., Falconi, M., Thayer, S. P., Zamboni, G., Lauwers, G. Y., Mino-Kenudson, M., et al. (2008) · Annals of Surgery · doi:10.1097/sla.0b013e31811f4449 · Cited by 490
Farnell, M. B., Pearson, R. K., Sarr, M. G., DiMagno, E. P., Burgart, L. J., Dahl, T. R., Foster, N., Sargent, D. J., & the Pancreas Cancer Working Group (2005) · Surgery · doi:10.1016/j.surg.2005.06.044 · Cited by 482
Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer
Pawlik, T. M., Gleisner, A. L., Cameron, J. L., Winter, J. M., Assumpcao, L., Lillemoe, K. D., Wolfgang, C., Hruban, R. H., Schulick, R. D., Yeo, C. J., et al. (2007) · Surgery · doi:10.1016/j.surg.2006.12.013 · Cited by 452
Bilimoria, K. Y., Bentrem, D. J., Ko, C. Y., Ritchey, J., Stewart, A. K., Winchester, D. P., & Talamonti, M. S. (2007) · Cancer · doi:10.1002/cncr.22852 · Cited by 427
Survival after resection for ductal adenocarcinoma of the pancreas
Sperti, C., Pasquali, C., Piccoli, A., & Pedrazzoli, S. (1996) · Journal of British Surgery · doi:10.1002/bjs.1800830512 · Cited by 370
Prognostic Nomogram for Patients Undergoing Resection for Adenocarcinoma of the Pancreas
Brennan, M. F., Kattan, M. W., Klimstra, D., & Conlon, K. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000133125.85489.07 · Cited by 367
Diabetes and the Risk of Pancreatic Cancer
Gullo, L., Pezzilli, R., & Morselli-Labate, A. M. (1994) · New England Journal of Medicine · doi:10.1056/nejm199407143310203 · Cited by 367
Slidell, M. B., Chang, D. C., Cameron, J. L., Wolfgang, C., Herman, J. M., Schulick, R. D., Choti, M. A., & Pawlik, T. M. (2008) · Annals of Surgical Oncology · doi:10.1245/s10434-007-9587-1 · Cited by 362
The Lymph Node Ratio is the Strongest Prognostic Factor after Resection of Pancreatic Cancer
Riediger, H., Keck, T., Wellner, U., zur Hausen, A., Adam, U., Hopt, U. T., & Makowiec, F. (2009) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-009-0919-2 · Cited by 358
Patterns of Recurrence After Curative Resection of Pancreatic Cancer, Based on Autopsy Findings
Hishinuma, S., Ogata, Y., Tomikawa, M., Ozawa, I., Hirabayashi, K., & Igarashi, S. (2006) · Journal of Gastrointestinal Surgery · doi:10.1016/j.gassur.2005.09.016 · Cited by 344
van de Poll‐Franse, L. V., Houterman, S., Janssen‐Heijnen, M. L. G., Dercksen, M. W., Coebergh, J. W. W., & Haak, H. R. (2007) · International Journal of Cancer · doi:10.1002/ijc.22532 · Cited by 324
Michalski, C. W., Kleeff, J., Wente, M. N., Diener, M. K., Büchler, M. W., & Friess, H. (2007) · British Journal of Surgery · doi:10.1002/bjs.5716 · Cited by 302
Self-citationPicozzi, V. J., Kozarek, R. A., & Traverso, L. W. (2003) · The American Journal of Surgery · doi:10.1016/s0002-9610(03)00051-5 · Cited by 262
Pancreatic Adenocarcinoma: The Actual 5-Year Survivors
Ferrone, C. R., Brennan, M. F., Gonen, M., Coit, D. G., Fong, Y., Chung, S., Tang, L., Klimstra, D., & Allen, P. J. (2008) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-007-0384-8 · Cited by 251
Schwarz, R. E., & Smith, D. D. (2006) · Annals of Surgical Oncology · doi:10.1245/s10434-006-9016-x · Cited by 230
Multivisceral Resection for Pancreatic Malignancies: Risk-Analysis and Long-Term Outcome
Hartwig, W., Hackert, T., Hinz, U., Hassenpflug, M., Strobel, O., Büchler, M. W., & Werner, J. (2009) · Annals of Surgery · doi:10.1097/sla.0b013e3181ad657b · Cited by 207
Self-citationfor the European Study Group of Pancreatic Cancer, Neoptolemos, J. P., Stocken, D. D., Tudur Smith, C., Bassi, C., Ghaneh, P., Owen, E., Moore, M., Padbury, R., Doi, R., et al. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6604838 · Cited by 204
Self-citationPancreatic cancer in type 1 and young-onset diabetes: systematic review and meta-analysis
Stevens, R. J., Roddam, A. W., & Beral, V (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603571 · Cited by 194
Factors influencing survival after resection for ductal adenocarcinoma of the head of the pancreas
Benassai, G., Mastrorilli, M., Quarto, G., Cappiello, P. A., Giani, U., Forestieri, P., & Mazzeo, F. (2000) · Journal of Surgical Oncology · doi:10.1002/(sici)1096-9098(200004)73:4<212::aid-jso5>3.0.co;2-d · Cited by 168
Berger, A. C., Meszoely, I. M., Ross, E. A., Watson, J. C., & Hoffman, J. P. (2004) · Annals of Surgical Oncology · doi:10.1245/aso.2004.11.025 · Cited by 133
Validation of a Postresection Pancreatic Adenocarcinoma Nomogram for Disease-Specific Survival
Ferrone, C. R., Kattan, M. W., Tomlinson, J. S., Thayer, S. P., Brennan, M. F., & Warshaw, A. L. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.8101 · Cited by 124
Wang, F., Gupta, S. N., & Holly, E. A. (2006) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0188 · Cited by 116
Wasif, N., Bentrem, D. J., Farrell, J. J., Ko, C. Y., Hines, O. J., Reber, H. A., & Tomlinson, J. S. (2010) · Cancer · doi:10.1002/cncr.25070 · Cited by 114
Preoperative Diabetes Mellitus and Long-Term Survival After Resection of Pancreatic Adenocarcinoma
Chu, C. K.-C., Mazo, A. E., Goodman, M. G., Egnatashvili, V., Sarmiento, J. M., Staley, C. A., Galloway, J. R., Adsay, V. N., Jacobs, S., & Kooby, D. A. (2009) · Annals of Surgical Oncology · doi:10.1245/s10434-009-0789-6 · Cited by 108
Predictive and Prognostic Value of CA 19-9 in Resected Pancreatic Adenocarcinoma
Barton, J. G., Bois, J. P., Sarr, M. G., Wood, C. M., Qin, R., Thomsen, K. M., Kendrick, M. L., & Farnell, M. B. (2009) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-009-0849-z · Cited by 93
Smith, R. A., Bosonnet, L., Ghaneh, P., Raraty, M. G. T., Sutton, R., Campbell, F., & Neoptolemos, J. P. (2008) · Digestive Surgery · doi:10.1159/000140961 · Cited by 78
Modeling Prognostic Factors in Resectable Pancreatic Adenocarcinomas
Botsis, T., Anagnostou, V., Hartvigsen, G., Hripcsak, G. M., & Weng, C. (2009) · Cancer Informatics · doi:10.4137/cin.s3835 · Cited by 16
Cited by
Kleeff, J., Korc, M., Apte, M., La Vecchia, C., Johnson, C. D., Biankin, A. V., Neale, R. E., Tempero, M., Tuveson, D. A., Hruban, R. H., et al. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.22 · Cited by 1,982
Bockhorn, M., Uzunoglu, F. G., Adham, M., Imrie, C., Milicevic, M., Sandberg, A. A., Asbun, H. J., Bassi, C., Büchler, M., Charnley, R. M., et al. (2014) · Surgery · doi:10.1016/j.surg.2014.02.001 · Cited by 967
Self-citationTol, J. A. M. G., Gouma, D. J., Bassi, C., Dervenis, C., Montorsi, M., Adham, M., Andrén-Sandberg, A., Asbun, H. J., Bockhorn, M., Büchler, M. W., et al. (2014) · Surgery · doi:10.1016/j.surg.2014.06.016 · Cited by 672
Self-citationHackert, T., Sachsenmaier, M., Hinz, U., Schneider, L., Michalski, C. W., Springfeld, C., Strobel, O., Jäger, D., Ulrich, A., & Büchler, M. W. (2016) · Annals of Surgery · doi:10.1097/sla.0000000000001850 · Cited by 529
Self-citationImprovement of surgical results for pancreatic cancer
Hartwig, W., Werner, J., Jäger, D., Debus, J., & Büchler, M. W. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70172-4 · Cited by 368
Self-citation
Metadata
- Authors
- Hartwig, W., Hackert, T., Hinz, U., Gluth, A., Bergmann, F., Strobel, O., Büchler, M. W., & Werner, J.
- Venue
- Annals of Surgery
- Published
- 2011-08
- Volume
- 254
- Issue
- 2
- Pages
- 311-319
- ISSN
- 0003-4932 (ISSN-L)
- OpenAlex
- W2090803746
- Cited by
- 412
- References
- 41
- FWCI
- 12.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.